Shanghai Haohai Biological Technology Co., Ltd. announced a repurchase and cancellation of 0.58 million H shares, completed on March 6, 2026. The repurchased shares constituted approximately 0.2561% of the existing H shares before the event, at an average price of HKD26.27 per share. Following this cancellation, the number of H shares stands at 35.93 million.

According to the disclosure, A shares remain at 190.20 million (excluding 3.85 million treasury shares). Consequently, the total number of issued shares (excluding treasury shares) is adjusted from 226.71 million to 226.13 million. No other changes in issued shares or treasury shares were reported.